Product Information

NORTREL 1-35 21 TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3584 per EA under NDC 00555900942. Its NADAC has been published 622 times since Nov 28, 2013.

FDA first approved this application on Feb 28, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NORTREL 1-35 21 TABLET

Norethindrone and Ethinyl Estradiol
$0.3584per EA

Strength

.035; 1 mg/1; mg/1

NDC

00555900942

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA072693

FDA Approved

2/28/1992

TE Code

AB

On Market Since

6/13/2001

Pharmacological Classes

Estrogen Receptor Agonists
Estrogen
Progesterone Congeners
Progestin

Price Statistics

The NADAC for NORTREL 1-35 21 TABLET has been published 622 times since Nov 28, 2013, and over the history we have for it it has declined 33.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3584 per EA
All-time high$0.7514 (Feb 10, 2021)
All-time low$0.2264 (Jun 21, 2023)
52-week high$0.4181
52-week low$0.3377
Median price$0.4507
Average price$0.4673
Largest weekly change+56.2% (Feb 19, 2020)
Weeks tracked622
Tracking sinceNov 28, 2013

Price History

1W

+6.1%

1M

+6.1%

3M

+1.7%

6M

-7.9%

1Y

-13.6%

3Y

+5.4%

5Y

-46.4%

All

-33.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Norethindrone and Ethinyl Estradiol market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of NORTREL 1-35 21 TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NORTREL 1-35 21 TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.3584 per EA (NDC 00555900942), effective Aug 19, 2026.

How has the price of NORTREL 1-35 21 TABLET changed over time?

Over the history we have for it, the NADAC for NORTREL 1-35 21 TABLET has declined 33.1%. It has been tracked across 622 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NORTREL 1-35 21 TABLET?

Since Nov 28, 2013, the NADAC for NORTREL 1-35 21 TABLET has ranged from a low of $0.2264 (Jun 21, 2023) to a high of $0.7514 (Feb 10, 2021), with a median of $0.4507 per EA.

Are there cheaper alternatives to NORTREL 1-35 21 TABLET?

No other NADAC-published product currently shares the active ingredient and strength of NORTREL 1-35 21 TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures NORTREL 1-35 21 TABLET?

NORTREL 1-35 21 TABLET (NDC 00555900942) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.